| Northwest Indiana Eye & Laser Center Pc | |
|
502 Marquette St, Valparaiso, IN 46383-2509 | |
| (219) 464-8223 | |
| (219) 531-2356 |
| Full Name | Northwest Indiana Eye & Laser Center Pc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 502 Marquette St, Valparaiso, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336212117 | NPI | - | NPPES |
| 200343240A | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Provider Name | Gregory S Densborn |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1164451167 PECOS PAC ID: 6002719135 Enrollment ID: I20040128000266 |
News Archive
Ingenix, a leading health information technology and services company, today announced it is making a specially-designed version of its Ingenix CareTracker practice management and electronic health record system available to Federally Qualified Health Centers. Ingenix CareTracker, which provides all of the capabilities physicians need to demonstrate "Meaningful Use," will offer these community health centers a cost-effective, Web-based, practice management and EHR option that will help them improve operational efficiency and patient care, and qualify for incentives offered by the federal government for demonstrating Meaningful Use of health IT.
Precision Biologics, in collaboration with investigators from Duke University, has been selected to present an abstract of findings from its Phase 2 clinical trial at the Annual Meeting of the American Society of Clinical Oncology.
Vern Greyn was standing in the raised bucket of a tractor, trimming dead branches off a tree, when he lost his balance. He fell 12 feet and struck his head on the concrete patio outside his house in this small farming town on the central Montana plains.
Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, announced today that it has submitted a 510(k) application to the United States Food and Drug Administration (FDA) to obtain marketing clearance for the use of its Duratech(TM) BioRegeneration Matrix to repair or replace the dura mater (the outermost membrane surrounding the brain) in various cranial surgical procedures.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $73.2 million for the fourth quarter ended December 31, 2014, a 38% increase compared to $53.1 million in revenue for the same period of 2013. For the fiscal year 2014, the company generated revenue of $278.4 million, a 34% increase compared to revenue of $207.9 million in 2013.
› Verified 8 days ago
| Provider Name | Richard S Carlson |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1073515938 PECOS PAC ID: 2769566322 Enrollment ID: I20080221000281 |
News Archive
Ingenix, a leading health information technology and services company, today announced it is making a specially-designed version of its Ingenix CareTracker practice management and electronic health record system available to Federally Qualified Health Centers. Ingenix CareTracker, which provides all of the capabilities physicians need to demonstrate "Meaningful Use," will offer these community health centers a cost-effective, Web-based, practice management and EHR option that will help them improve operational efficiency and patient care, and qualify for incentives offered by the federal government for demonstrating Meaningful Use of health IT.
Precision Biologics, in collaboration with investigators from Duke University, has been selected to present an abstract of findings from its Phase 2 clinical trial at the Annual Meeting of the American Society of Clinical Oncology.
Vern Greyn was standing in the raised bucket of a tractor, trimming dead branches off a tree, when he lost his balance. He fell 12 feet and struck his head on the concrete patio outside his house in this small farming town on the central Montana plains.
Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, announced today that it has submitted a 510(k) application to the United States Food and Drug Administration (FDA) to obtain marketing clearance for the use of its Duratech(TM) BioRegeneration Matrix to repair or replace the dura mater (the outermost membrane surrounding the brain) in various cranial surgical procedures.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $73.2 million for the fourth quarter ended December 31, 2014, a 38% increase compared to $53.1 million in revenue for the same period of 2013. For the fiscal year 2014, the company generated revenue of $278.4 million, a 34% increase compared to revenue of $207.9 million in 2013.
› Verified 8 days ago
| Provider Name | Scott Allen Buck |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1801856943 PECOS PAC ID: 4789660937 Enrollment ID: I20080429000368 |
News Archive
Ingenix, a leading health information technology and services company, today announced it is making a specially-designed version of its Ingenix CareTracker practice management and electronic health record system available to Federally Qualified Health Centers. Ingenix CareTracker, which provides all of the capabilities physicians need to demonstrate "Meaningful Use," will offer these community health centers a cost-effective, Web-based, practice management and EHR option that will help them improve operational efficiency and patient care, and qualify for incentives offered by the federal government for demonstrating Meaningful Use of health IT.
Precision Biologics, in collaboration with investigators from Duke University, has been selected to present an abstract of findings from its Phase 2 clinical trial at the Annual Meeting of the American Society of Clinical Oncology.
Vern Greyn was standing in the raised bucket of a tractor, trimming dead branches off a tree, when he lost his balance. He fell 12 feet and struck his head on the concrete patio outside his house in this small farming town on the central Montana plains.
Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, announced today that it has submitted a 510(k) application to the United States Food and Drug Administration (FDA) to obtain marketing clearance for the use of its Duratech(TM) BioRegeneration Matrix to repair or replace the dura mater (the outermost membrane surrounding the brain) in various cranial surgical procedures.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $73.2 million for the fourth quarter ended December 31, 2014, a 38% increase compared to $53.1 million in revenue for the same period of 2013. For the fiscal year 2014, the company generated revenue of $278.4 million, a 34% increase compared to revenue of $207.9 million in 2013.
› Verified 8 days ago
| Provider Name | Stephen R Buck |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1134235849 PECOS PAC ID: 0345226593 Enrollment ID: I20080429000485 |
News Archive
Ingenix, a leading health information technology and services company, today announced it is making a specially-designed version of its Ingenix CareTracker practice management and electronic health record system available to Federally Qualified Health Centers. Ingenix CareTracker, which provides all of the capabilities physicians need to demonstrate "Meaningful Use," will offer these community health centers a cost-effective, Web-based, practice management and EHR option that will help them improve operational efficiency and patient care, and qualify for incentives offered by the federal government for demonstrating Meaningful Use of health IT.
Precision Biologics, in collaboration with investigators from Duke University, has been selected to present an abstract of findings from its Phase 2 clinical trial at the Annual Meeting of the American Society of Clinical Oncology.
Vern Greyn was standing in the raised bucket of a tractor, trimming dead branches off a tree, when he lost his balance. He fell 12 feet and struck his head on the concrete patio outside his house in this small farming town on the central Montana plains.
Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, announced today that it has submitted a 510(k) application to the United States Food and Drug Administration (FDA) to obtain marketing clearance for the use of its Duratech(TM) BioRegeneration Matrix to repair or replace the dura mater (the outermost membrane surrounding the brain) in various cranial surgical procedures.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $73.2 million for the fourth quarter ended December 31, 2014, a 38% increase compared to $53.1 million in revenue for the same period of 2013. For the fiscal year 2014, the company generated revenue of $278.4 million, a 34% increase compared to revenue of $207.9 million in 2013.
› Verified 8 days ago
| Provider Name | Ricky L Weidow |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1639177793 PECOS PAC ID: 8921022328 Enrollment ID: I20091223000119 |
News Archive
Ingenix, a leading health information technology and services company, today announced it is making a specially-designed version of its Ingenix CareTracker practice management and electronic health record system available to Federally Qualified Health Centers. Ingenix CareTracker, which provides all of the capabilities physicians need to demonstrate "Meaningful Use," will offer these community health centers a cost-effective, Web-based, practice management and EHR option that will help them improve operational efficiency and patient care, and qualify for incentives offered by the federal government for demonstrating Meaningful Use of health IT.
Precision Biologics, in collaboration with investigators from Duke University, has been selected to present an abstract of findings from its Phase 2 clinical trial at the Annual Meeting of the American Society of Clinical Oncology.
Vern Greyn was standing in the raised bucket of a tractor, trimming dead branches off a tree, when he lost his balance. He fell 12 feet and struck his head on the concrete patio outside his house in this small farming town on the central Montana plains.
Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, announced today that it has submitted a 510(k) application to the United States Food and Drug Administration (FDA) to obtain marketing clearance for the use of its Duratech(TM) BioRegeneration Matrix to repair or replace the dura mater (the outermost membrane surrounding the brain) in various cranial surgical procedures.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $73.2 million for the fourth quarter ended December 31, 2014, a 38% increase compared to $53.1 million in revenue for the same period of 2013. For the fiscal year 2014, the company generated revenue of $278.4 million, a 34% increase compared to revenue of $207.9 million in 2013.
› Verified 8 days ago
| Provider Name | David F Ryser |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1528061363 PECOS PAC ID: 6507963329 Enrollment ID: I20100305000665 |
News Archive
Ingenix, a leading health information technology and services company, today announced it is making a specially-designed version of its Ingenix CareTracker practice management and electronic health record system available to Federally Qualified Health Centers. Ingenix CareTracker, which provides all of the capabilities physicians need to demonstrate "Meaningful Use," will offer these community health centers a cost-effective, Web-based, practice management and EHR option that will help them improve operational efficiency and patient care, and qualify for incentives offered by the federal government for demonstrating Meaningful Use of health IT.
Precision Biologics, in collaboration with investigators from Duke University, has been selected to present an abstract of findings from its Phase 2 clinical trial at the Annual Meeting of the American Society of Clinical Oncology.
Vern Greyn was standing in the raised bucket of a tractor, trimming dead branches off a tree, when he lost his balance. He fell 12 feet and struck his head on the concrete patio outside his house in this small farming town on the central Montana plains.
Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, announced today that it has submitted a 510(k) application to the United States Food and Drug Administration (FDA) to obtain marketing clearance for the use of its Duratech(TM) BioRegeneration Matrix to repair or replace the dura mater (the outermost membrane surrounding the brain) in various cranial surgical procedures.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $73.2 million for the fourth quarter ended December 31, 2014, a 38% increase compared to $53.1 million in revenue for the same period of 2013. For the fiscal year 2014, the company generated revenue of $278.4 million, a 34% increase compared to revenue of $207.9 million in 2013.
› Verified 8 days ago
| Provider Name | Ellyn M Lovett |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1558468447 PECOS PAC ID: 6002214418 Enrollment ID: I20211014001764 |
News Archive
Ingenix, a leading health information technology and services company, today announced it is making a specially-designed version of its Ingenix CareTracker practice management and electronic health record system available to Federally Qualified Health Centers. Ingenix CareTracker, which provides all of the capabilities physicians need to demonstrate "Meaningful Use," will offer these community health centers a cost-effective, Web-based, practice management and EHR option that will help them improve operational efficiency and patient care, and qualify for incentives offered by the federal government for demonstrating Meaningful Use of health IT.
Precision Biologics, in collaboration with investigators from Duke University, has been selected to present an abstract of findings from its Phase 2 clinical trial at the Annual Meeting of the American Society of Clinical Oncology.
Vern Greyn was standing in the raised bucket of a tractor, trimming dead branches off a tree, when he lost his balance. He fell 12 feet and struck his head on the concrete patio outside his house in this small farming town on the central Montana plains.
Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, announced today that it has submitted a 510(k) application to the United States Food and Drug Administration (FDA) to obtain marketing clearance for the use of its Duratech(TM) BioRegeneration Matrix to repair or replace the dura mater (the outermost membrane surrounding the brain) in various cranial surgical procedures.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $73.2 million for the fourth quarter ended December 31, 2014, a 38% increase compared to $53.1 million in revenue for the same period of 2013. For the fiscal year 2014, the company generated revenue of $278.4 million, a 34% increase compared to revenue of $207.9 million in 2013.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Northwest Indiana Eye & Laser Center Pc 502 Marquette St, Valparaiso, IN 46383-2509 Ph: (219) 464-8223 | Northwest Indiana Eye & Laser Center Pc 502 Marquette St, Valparaiso, IN 46383-2509 Ph: (219) 464-8223 |
News Archive
Ingenix, a leading health information technology and services company, today announced it is making a specially-designed version of its Ingenix CareTracker practice management and electronic health record system available to Federally Qualified Health Centers. Ingenix CareTracker, which provides all of the capabilities physicians need to demonstrate "Meaningful Use," will offer these community health centers a cost-effective, Web-based, practice management and EHR option that will help them improve operational efficiency and patient care, and qualify for incentives offered by the federal government for demonstrating Meaningful Use of health IT.
Precision Biologics, in collaboration with investigators from Duke University, has been selected to present an abstract of findings from its Phase 2 clinical trial at the Annual Meeting of the American Society of Clinical Oncology.
Vern Greyn was standing in the raised bucket of a tractor, trimming dead branches off a tree, when he lost his balance. He fell 12 feet and struck his head on the concrete patio outside his house in this small farming town on the central Montana plains.
Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, announced today that it has submitted a 510(k) application to the United States Food and Drug Administration (FDA) to obtain marketing clearance for the use of its Duratech(TM) BioRegeneration Matrix to repair or replace the dura mater (the outermost membrane surrounding the brain) in various cranial surgical procedures.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $73.2 million for the fourth quarter ended December 31, 2014, a 38% increase compared to $53.1 million in revenue for the same period of 2013. For the fiscal year 2014, the company generated revenue of $278.4 million, a 34% increase compared to revenue of $207.9 million in 2013.
› Verified 8 days ago
Dr. Richard Scott Carlson, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 502 Marquette St, Valparaiso, IN 46383 Phone: 219-464-8223 Fax: 219-531-2356 | |
Stephen R Buck, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 502 Marquette St, Valparaiso, IN 46383 Phone: 219-464-8223 Fax: 219-531-2356 | |
Stanley N. Blackman, O.d., P.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2009 Roosevelt Rd, Suite D, Valparaiso, IN 46383 Phone: 219-462-5501 Fax: 219-462-3238 | |
Nikole T Schilling, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2101 Burlington Beach Rd., Valparaiso, IN 46383 Phone: 219-462-0309 Fax: 219-464-4291 | |
Dr. Phillip George Koultourides, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2400 Morthland Dr, Valparaiso, IN 46383 Phone: 219-465-2788 Fax: 219-465-2785 | |
D/b/a Lewyckyj-taglia- Felton Eye Clinics Optometrist Medicare: Medicare Enrolled Practice Location: 2101 Burlington Beach Rd, Valparaiso, IN 46383 Phone: 219-462-0309 Fax: 219-464-4291 |